TASCINI, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 9.201
AS - Asia 8.558
EU - Europa 4.059
SA - Sud America 1.858
AF - Africa 233
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 7
Totale 23.933
Nazione #
US - Stati Uniti d'America 8.927
SG - Singapore 4.542
IT - Italia 1.556
BR - Brasile 1.517
CN - Cina 1.271
HK - Hong Kong 986
VN - Vietnam 787
RU - Federazione Russa 467
FR - Francia 398
DE - Germania 308
IE - Irlanda 305
IN - India 220
GB - Regno Unito 183
FI - Finlandia 176
UA - Ucraina 135
CA - Canada 125
AR - Argentina 123
BD - Bangladesh 117
SE - Svezia 110
TR - Turchia 85
MX - Messico 83
KR - Corea 82
AT - Austria 80
NL - Olanda 71
IQ - Iraq 70
ZA - Sudafrica 70
ID - Indonesia 65
EC - Ecuador 58
JP - Giappone 54
ES - Italia 51
CO - Colombia 48
PL - Polonia 48
PK - Pakistan 43
MA - Marocco 34
BE - Belgio 27
UZ - Uzbekistan 25
VE - Venezuela 25
CL - Cile 23
SA - Arabia Saudita 22
PE - Perù 21
PY - Paraguay 20
TG - Togo 19
CH - Svizzera 18
JO - Giordania 18
TN - Tunisia 18
EG - Egitto 16
KE - Kenya 16
LT - Lituania 14
NP - Nepal 14
PH - Filippine 14
DZ - Algeria 13
LB - Libano 13
AE - Emirati Arabi Uniti 11
AZ - Azerbaigian 11
TW - Taiwan 11
UY - Uruguay 11
AL - Albania 10
CZ - Repubblica Ceca 10
IL - Israele 10
JM - Giamaica 10
AU - Australia 9
BO - Bolivia 9
HR - Croazia 9
KZ - Kazakistan 9
OM - Oman 9
PT - Portogallo 9
BG - Bulgaria 8
CR - Costa Rica 8
DO - Repubblica Dominicana 8
GR - Grecia 8
LV - Lettonia 8
KG - Kirghizistan 7
PA - Panama 7
RO - Romania 7
RS - Serbia 7
TH - Thailandia 7
CI - Costa d'Avorio 6
ET - Etiopia 6
GE - Georgia 6
HU - Ungheria 6
NI - Nicaragua 6
AO - Angola 5
BB - Barbados 5
BH - Bahrain 5
BY - Bielorussia 5
DK - Danimarca 5
GT - Guatemala 5
MY - Malesia 5
SY - Repubblica araba siriana 5
AM - Armenia 4
BZ - Belize 4
KH - Cambogia 4
KW - Kuwait 4
LK - Sri Lanka 4
MD - Moldavia 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
EU - Europa 3
Totale 23.857
Città #
Singapore 1.636
Ashburn 966
Hong Kong 966
San Jose 768
Beijing 513
Chandler 464
Boardman 432
Redmond 384
Council Bluffs 383
Lauterbourg 313
Fairfield 307
Dublin 287
Woodbridge 281
Ho Chi Minh City 266
Wilmington 252
Princeton 246
Dallas 245
Houston 224
Los Angeles 222
Udine 183
Ann Arbor 181
Redondo Beach 148
Seattle 145
Hanoi 140
Cambridge 131
São Paulo 127
Buffalo 125
Milan 123
Santa Clara 115
New York 103
Helsinki 96
Mumbai 89
Rome 88
Hefei 85
Seoul 78
Dong Ket 76
Munich 68
Frankfurt am Main 66
Nuremberg 65
The Dalles 64
Belluno 56
Jacksonville 54
Dearborn 52
Tokyo 51
Chicago 48
Montreal 45
Norwalk 44
Rio de Janeiro 43
Trieste 43
Johannesburg 42
Orem 42
Lappeenranta 41
Vienna 40
Izmir 39
Atlanta 38
Mexico City 35
Warsaw 35
Belo Horizonte 34
Denver 34
Ogden 34
Florence 33
San Diego 32
Brasília 31
Naples 31
Amsterdam 30
Guangzhou 29
Phoenix 29
Bologna 27
Da Nang 27
Haiphong 27
London 27
Toronto 27
Brooklyn 25
Des Moines 25
Brussels 24
Baghdad 23
Turku 23
Chennai 22
Curitiba 22
Porto Alegre 22
Dhaka 21
Düsseldorf 21
Stockholm 21
Tashkent 21
Poplar 20
Bogotá 19
Lomé 19
Venice 19
Buenos Aires 18
Quito 18
Washington 18
Hyderabad 17
Manchester 17
San Francisco 17
Shanghai 17
Biên Hòa 16
Boston 16
Guarulhos 16
Hải Dương 16
Turin 16
Totale 13.200
Nome #
Lessons learnt while designing and conducting a longitudinal study from the first Italian COVID-19 pandemic wave up to 3 years 291
Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts 245
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 215
Gestione Diagnostico-Terapeutica del Paziente di Area Critica con Infezione Grave da Patogeni Batterici Multiresistenti 208
MR-proADM as prognostic factor of outcome in COVID-19 patients 193
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 186
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 184
Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience 183
An Italian consensus for invasive candidiasis management (ITALIC) 176
Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals 171
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 169
Ampicillin and Ceftobiprole Combination for the Treatment of Enterococcus faecalis Invasive Infections: “The Times They Are A-Changin” 164
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy 154
Independent risk factors for mortality in critically ill patients with candidemia on Italian Internal Medicine Wards 153
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 153
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 151
Lung Ultrasound Signs and Their Correlation With Clinical Symptoms in COVID-19 Pregnant Women: The “PINK-CO” Observational Study 148
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care 145
Hyposmia and Dysgeusia in COVID-19: Indication to Swab Test and Clue of CNS Involvement 144
Predictors of choice of initial antifungal treatment in intraabdominal candidiasis 143
Eravacycline: Data Based on Real Evidence 139
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery 136
Population pharmacokinetics and pharmacodynamic target attainment of isavuconazole against aspergillus fumigatus and aspergillus flavus in adult patients with invasive fungal diseases: Should therapeutic drug monitoring for isavuconazole be considered as mandatory as for the other mold-active azoles? 134
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: Findings from a multicenter prospective observational study 132
The Fall in Antibody Response to SARS-CoV-2: A Longitudinal Study of Asymptomatic to Critically Ill Patients up to 10 Months after Recovery 130
The role of biofilm forming on mortality in patients with candidemia: a study derived from real world data 129
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis 128
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study 125
Ceftobiprole: drug evaluation and place in therapy 123
Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination 122
Mental health symptoms one year after acute COVID-19 infection: prevalence and risk factors 122
INFEZIONI da GRAM POSITIVI per QUADRO SINDROMICO Dal laboratorio alla clinica 121
Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19 121
Detection of SARS-CoV-2 infection prevalence in 860 cancer patients with a combined screening procedure including triage, molecular nasopharyngeal swabs and rapid serological test. A report from the first epidemic wave 121
Covid-19 and the role of smoking: the protocol of the multicentric prospective study COSMO-IT (COvid19 and SMOking in ITaly). 119
Risk factors for ventilator associated pneumonia due to carbapenemase-producing Klebsiella pneumoniae in mechanically ventilated patients with tracheal and rectal colonization 117
L'uso dei farmaci antimicrobici in terapia intensiva - Letteratura ragionata dell'antibiogramma 116
One Word to Describe My Experience as a COVID-19 Survivor Six Months after Its Onset: Findings of a Qualitative Study 116
A cluster of COVID-19 cases in a small Italian town: a successful example of contact tracing and swab collection 115
Reading and understanding an antibiogram 115
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients 115
Acid-suppressant therapy does not influence absorption of azoles used in candidemia 113
Risk factors and outcome of c. Difficile infection after hematopoietic stem cell transplantation 112
KPC-producing Klebsiella pneumoniae gut decolonisation following ceftazidime/avibactam-based combination therapy: A retrospective observational study 112
Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients 112
The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia 111
Use of colistin in adult patients: A cross-sectional study 111
Screening procedure for SARS-CoV-2 infection combining triage, nasopharyngeal swab and serological test in allogeneic stem cell transplantation recipients undergoing outpatient posttransplant follow-up 111
Prognostic role of malnutrition diagnosed by bioelectrical impedance vector analysis in older adults hospitalized with covid-19 pneumonia: A prospective study 111
Safety and effcacy of subcutaneous administration of Beta-Lactams: a Systematic Review and Meta-analysis. (In: The 20th European Doctoral Conference in Nursing Science – EDCNS) 110
Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature 110
Local occurrence and fast spread of B.1.1.7 lineage: A glimpse into Friuli Venezia Giulia 108
Candidemia in Patients with Body Temperature Below 37°C and Admitted to Internal Medicine Wards: Assessment of Risk Factors 107
Echocardiographic Comparison of COVID-19 Patients with or without Prior Biochemical Evidence of Cardiac Injury after Recovery 107
Higher levels of IL-6 early after tocilizumab distinguish survivors from non-survivors in COVID-19 pneumonia: a possible indication for deeper targeting IL-6 106
Extracellular vesicle features are associated with COVID-19 severity 105
Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection 104
A Randomized Controlled Trial to Examine the Efficacy and Safety of a New Super-Oxidized Solution for the Management of Wide Postsurgical Lesions of the Diabetic Foot 103
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients 101
A single-staggered dose of calcineurin inhibitor may be associated with neurotoxicity and nephrotoxicity immediately after liver transplantation 101
Antibody response and risk of reinfection over 2 years among the patients with first wave of COVID-19 99
A Novel Immunosuppressive Strategy Combined with Preemptive Antiviral Therapy Improves the Eighteen-Month Mortality in HCV Recipients Transplanted with Aged Livers 99
D-Dimer as Biomarker for Early Prediction of Clinical Outcomes in Patients With Severe Invasive Infections Due to Streptococcus Pneumoniae and Neisseria Meningitidis 98
Persistence of fatigue in the absence of pathophysiological mechanisms in some patients more than 2 years after the original SARS-CoV-2 infection 97
Enterobacterales multiresistenti - Dal laboratorio alla clinica 97
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 96
Cefditoren: a clinical overview 95
A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway 95
L’interpretazione del fenotipo antibiotico come strumento per il clinico. 94
A prediction rule for early recognition of patients with candidemia in Internal Medicine: results from an Italian, multicentric, case-control study 93
COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomes 92
Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literature 91
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience 90
2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS 90
Mid-regional pro-adrenomedullin as a supplementary tool to clinical parameters in cases of suspicion of infection in the emergency department 90
Longest incubation period of Mycobacterium chimaera infection after cardiac surgery 89
Renal Function and Its Impact on the Concentration of Ceftazidime-Avibactam: A cross-sectional study 88
A Rapid High-Performance Liquid Chromatography Method to Measure Linezolid and Daptomycin Concentrations in Human Plasma 88
Approach to patients with COVID-19 disease: The procedure in Udine 88
Accuracy of point-of-care ultrasound to identify the source of infection in septic patients: a prospective study-comment 87
A NEW IMMUNOSUPPRESSIVE STRATEGY COMBINED WITH EARLY ANTIVIRAL THERAPY IMPROVES SURVIVAL AND LEADS TO HCV ERADICATION AT THE SAME COST OF THE HBV PROPHYLAXIS 3 YEARS AFTER LIVER TRANSPLANTATION 87
PK/PD Analysis of High-Dose Daptomycin Use in the Treatment of Bone and Joint Infections: Data from a Real-World Setting 87
Safety and Pharmacokinetic Profiles of Subcutaneous Administration of Beta-Lactams: A Systematic Review 86
Barotrauma during Noninvasive Respiratory Support in COVID-19 Pneumonia Outside ICU: The Ancillary COVIMIX-2 Study 86
L'uso dei Farmaci Antifungini nel Paziente Critico. Le Infezioni Fungine nel Paziente Critico dal Laboratorio alla Clinica per Ottimizzare la Diagnosi e la Terapia 86
Monitoring the SPREAD of the SARS-CoV-2 lineage B.1.621 in Udine, Italy 86
Pragmatic overview on acute bacterial and fungal infections of the central nervous system: a holistic update from diagnosis to treatment 85
Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection 85
COVID-19 Survivors Are Still in Need of Neuropsychiatric Support Two Years after Infection 84
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality 84
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 84
Liposome composition of colistin for intravenous, oral, and cutaneous therapheutic use, and process for its preparation 84
A dangerous job 84
Antibody, cell-mediated response and infection susceptibility in allogeneic hematopoietic stem cell recipients after COVID-19 mRNA vaccination 83
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 83
SARS-CoV-2 and influenza vaccine hesitancy during the COVID-19 pandemic in a dynamic perspective 82
A microbiological and structural analysis of the interplay between sulbactam/durlobactam and imipenem against penicillin-binding proteins (PBPs) of Acinetobacter spp 82
The Subcutaneous Administration of Beta-Lactams: A Case Report and Literary Review—To Do Small Things in a Great Way 81
A Position Paper on IgM-Enriched Intravenous Immunoglobulin Adjunctive Therapy in Severe Acute Bacterial Infections: The TO-PIRO SCORE Proposal 81
A proposal for distinguishing between bacterial and viral meningitis using genetic programming and decision trees 81
Totale 11.764
Categoria #
all - tutte 127.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.712


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021115 0 0 0 0 0 0 0 0 0 0 0 115
2021/20221.478 78 78 74 50 85 31 52 105 95 222 331 277
2022/20231.506 271 124 21 141 121 410 47 70 168 15 65 53
2023/2024922 102 46 60 52 98 108 41 147 59 83 37 89
2024/20255.961 143 364 215 250 136 263 403 309 837 519 966 1.556
2025/202612.112 831 1.277 1.238 1.433 1.728 968 1.447 472 632 975 872 239
Totale 25.312